5 Pharmaceutical preparations for treating cancers, namely, hairy cell leukemia, Kaposi's sarcoma, multiple myeloma, chronic myelogenous leukemia, malignant melanoma; pharmaceutical preparations for regulating immune system; pharmaceutical preparations for treating hepatitis-chronic hepatitis B, chronic hepatitis C, all the aforesaid goods being for humans